HOPKINTON, Mass., April 28 Caliper LifeSciences, Inc. (Nasdaq: CALP) today announced that the Texas A&M HealthScience Center Research Foundation (HSCRF) is using the IVIS Spectrum imagingsystem to speed the development of more effective therapeutic treatments fortuberculosis. Research efforts and the purchase of the IVIS system are fundedthrough a grant to the Texas A&M Health Science Center from the Bill & MelindaGates Foundation.
Tuberculosis currently affects nearly one-third of the world's populationand remains a global threat due to severe and drug-resistant strains.According to the World Health Organization, tuberculosis is one of the mostserious infectious diseases in the world. Caliper is dedicated to assistingthe global fight against infectious diseases and aiding the discovery oflife-saving treatments.
Researchers at the Texas A&M Health Science Center College of Medicine anda consortium of leading tuberculosis researchers at Washington University andStanford University School of Medicine are actively studying tuberculosisinfections in live animals using in vivo imaging technology. Caliper's IVISSpectrum was specifically chosen for its highly sensitive luminescencedetection and ability to successfully image, track and quantify tuberculosisinfections using fluorescence. The IVIS system enables researchers tovisualize the progression of the disease and impact of therapeutic candidatesin real time. This rapid evaluation of in vivo efficacy allows researchers toquickly adapt efforts and progress towards effective treatments for thedisease.
"We are quite optimistic that this research collaboration will uncover newand promising discoveries in the fight against tuberculosis," said KevinHrusovsky, CEO of Caliper Life Sciences. "Caliper's imaging technology hasproven to be integral in other discovery efforts for finding new ways andtreatments to combat infectious disease. This is a great opportunity toexploit Caliper's imaging technology to make a major impact in this world."
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of leading-edge technologiesenabling researchers in the life sciences industry to create life-saving andenhancing medicines and diagnostic tests more quickly and efficiently. Caliperis aggressively innovating new technology to bridge the gap between in vitroassays and in vivo results and then translating those results into cures forhuman disease. Caliper's portfolio of offerings includes state-of-the-artmicrofluidics, lab automation & liquid handling, optical imaging technologies,and discovery & development outsourcing solutions. For more information pleasevisit www.caliperLS.com.
Caliper and IVIS are registered trademarks, and Spectrum is a trademark,of Caliper Life Sciences, Inc.
SOURCE Caliper Life Sciences, Inc.